A Randomized, 4-way Crossover Study to Evaluate the Food Effect and the Absorption Profile of Investigational Product of "Ibuprofen Controlled-Release Tablets 600 mg" in Comparison to the Reference Standard Ibuprofen Tablets 200 mg in Normal Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2018
At a glance
- Drugs Ibuprofen (Primary) ; Ibuprofen
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Overseas Pharmaceuticals
- 20 Aug 2018 Planned End Date changed from 24 Jun 2018 to 31 Dec 2020.
- 20 Aug 2018 Planned primary completion date changed from 13 Apr 2018 to 30 Jun 2020.
- 07 Feb 2018 New trial record